1 December 2004 in Drug Discovery Today
1 April 2004 in Drug Discovery Today
1 December 2004 in Drug Discovery Today
4 January 2003 in Analytical Chemistry
1 August 2003 in Current Drug Metabolism
BNBentham Science Publisher A-E.F. Nassar
Bentham Science Publisher A-E.F. Nassar
An assay method for identification of metabolites from in vitro microsomal incubations was developed for use in the early stage of drug discovery. We have developed a practical approach which involves integrated sample generation, sample preparation, bioanalysis, and data handling to maximize sample throughput and speed up the process for identification of metabolites. The assay system consisted of a robotic liquid handler (Genesis workstation) to generate and process samples, PALLAS MetabolExpert software to predict possible metabolites, exact mass measurement via a tandem quadrupole time-of-flight mass spectrometer (QTOF-MS) coupled with liquid chromatography to analyze samples, MetaboLynx software to find potential metabolites and Advanced Chemistry Development / MS (ACD / MS) software to provide guidance to the most likely hypothetical metabolite chemical structures. For purposes of evaluating this new method, dextromethorphan, alprenolol, and propranolol were incubated separately for up to 60 minutes with rat and human hepatic microsomes. The incubation and sample preparation were carried out in 96-well plates using the Genesis workstation. The bioanalysis was performed by LC-MS / MS using QTOF with MetaboLynx software to find metabolites. Metabolic products formed in vitro by rat and human microsomes were separated using an analytical column C18 with gradient elution at flow rate of 250 μl / min. The internal mass calibration was performed by continuous postcolumn infusion of Haloperidol. The mass spectra from incubations containing NADPH were compared to those without NADPH (control) using the MetaboLynx software to find potential metabolites. Finally, the MS / MS spectra were processed by the ACD / MS software to predict the chemical structure. MetaboLynx software successfully identified metabolites for each of the drugs studied by automatically discerning expected metabolites. Exact differences in masses between each metabolite and parent drug were measured from five replicate sample injections. All measured values are accurate to less than 0.001Da or 3.8 ppm with the standard deviation within 0.0015 Da, which allowed good prediction / confirmation of empirical formulae. Hypothetical chemical structures were achieved by the ACD / MS software and provided a useful tool to assist in prediction of the metabolic pathways of the drugs. The metabolites identified were in good agreement with previously published results for all three compounds. This new method will greatly enhance throughput, which in turn will facilitate our ability to rapidly provide this guidance to the synthetic chemist.
1 September 2003 in Journal of Chromatographic Science
A method for metabolite identification in drug discovery and development utilizing online hydrogen-deuterium (H-D) exchange and a tandem-quadrupole time-of-flight mass spectrometer coupled with liquid chromatography has been developed for the first time. For purposes of evaluating this method, nimodipine is incubated with rat, dog, monkey, and human hepatic microsomes over a 60-min period. This procedure involves the replacement of H2O with D2O in the mobile phase. The equilibration time required to change (switch) from H2O in the mobile phase into D2O is approximately 10 min. There is no significant difference between the retention times in H2O or D2O mobile phase. The results show that the separations of nimodipine and its metabolites and the subsequent H-D exchanges were achieved online. This leads to the identification of nimodipine metabolites formed in vitro. Five metabolites of nimodipine are identified and characterized. These metabolites are formed by dehydrogenation, demethylation of methoxy group, cleavage of the ester groups by hydrolysis or oxidation, and hydroxylation of methyl groups. The combination of the H-D exchange process and the assay system is found to be a powerful tool for the study of metabolite identification. The method appears to be highly desirable for identification of metabolites produced by dehydrogenation, oxidation, and dealkylation, which are discussed herein. This method also greatly enhances throughput, which in turn facilitates the ability to rapidly provide metabolite elucidation.